Transgender-Inclusive Health Benefits on the Rise

Transgender-inclusive health care benefits offerings are on the rise—29% of U.S. employers currently offer the benefit, up from 12% in 2016.

I chatted with Julie Stich, CEBS, Vice President of Content at the International Foundation about the increasing number of employers offering transgender-inclusive health care benefits. She said, when searching for meaningful employment, individuals look for employers with cultures that resonate. Often this involves inclusiveness and employers that offer a range of benefits to serve a diverse population. Organizations are seeking top talent, and offering an inclusive benefits package sets them apart from their competition.

Transgender-Inclusive Health Benefits on the Rise

The Employee Benefits Survey finds that among U.S. employer-provided health plans:

  • 22% offer gender-reassignment/affirmation surgery (up from 8% in 2016)
  • 25% provide mental health counseling pre- and/or post-surgery (up from 11% in 2016)
  • 24% cover prescription drug therapy (hormone replacement therapy, etc.) (up from 9% in 2016)
  • 24% include physician visits (up from 10% in 2016)
  • 23% cover lab tests (up from 9% in 2016)
  • 3% include cosmetic surgery (facial feminization, Adam’s apple reduction, etc.) (up from 2% in 2016)

Transgender-inclusive health benefits are more commonly provided by large organizations, those with 10,000 or more employees. In 2016, 27% of large employers offered the benefit; two years later, that number has increased to 52%.

[Related Reading: Innovative Health Offerings: 24 Considerations for Your Plan]

For smaller organizations (those with fewer than 50 employees), 4% offered transgender-inclusive health benefits in 2016. That number increased to 10% in 2018.

Julie also added that offering transgender-inclusive health benefits is a way for employers to remain competitive in attracting talent without breaking the bank. Typically, this type of benefit is appreciated but not used frequently.

Anne Patterson
Social Media and Communications Associate at the International Foundation

Evidence, Insight and Strategy for Optimizing Health Benefits

The latest from Word on Benefits:

Anne Patterson

Social Marketing and Communications Strategist at the International Foundation

Favorite Foundation Product: The innovative member survey efforts and results from the research team.

Benefits-Telated Topics That Interest Her Most: Health care, nontraditional wellness initiatives, employee benefit communication.

Personal Insight: It’s all about balance with Anne. She loves to run and enjoys a good culinary adventure. She’ll jump at the chance to travel or to spend fun times with family and friends, but she’ll also take time to catch her breath with an occasional Netflix binge or diving into a classic novel.

Recommended Posts

Open pharmacy pill containers on a pile of 20 dollar bills.

What the Executive Order Increasing PBM Fee Transparency Means for Employers

Amanda Wilke, CEBS
 

On April 15, 2025, President Trump signed the executive order (EO) “Lowering Drug Prices by Once Again Putting Americans First,” which includes specific actions to be taken by federal agencies to reduce prescription drug costs, improve transparency and increase competition in the […]

GLP-1 Drug Coverage Continues to Rise in Canada 

Rebecca Plier
 

New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods  A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]

GLP-1 Drugs Responsible for Over Ten Percent of Annual Claims 

Rebecca Plier
 

New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms   A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]